Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.

ABSTRACT:

SUBMITTER: Collins SE 

PROVIDER: S-EPMC9875110 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature